Imugene's drug gets an unusually early tick of approval
Imugene CEO Leslie Chong says the company's cancer drug trial has progressed faster than many even in her own company have expected.
With a low hazard ratio now confirmed for its flagship drug, Chong says the next challenge is deciding what to do!
https://www.******.com.au/media/imugenes-drug-gets-an-unusually-early-tick-of-approval?videoId=5688
GLAH...
- Forums
- ASX - By Stock
- Ann: Imugene HER Vaxx shows positive Overall Survival in trial
Imugene's drug gets an unusually early tick of approval Imugene...
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.3¢ | $339.4K | 6.365M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 895592 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 672708 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 845592 | 0.053 |
21 | 2719942 | 0.052 |
37 | 3800174 | 0.051 |
70 | 5690066 | 0.050 |
16 | 2155346 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 672708 | 10 |
0.055 | 2964674 | 13 |
0.056 | 2227496 | 13 |
0.057 | 1068065 | 8 |
0.058 | 725800 | 5 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online